期刊文献+

年轻吸烟者血清可溶性CD40配体水平测定的临床意义

Clinical significance of determination of soluble CD40 ligand in young smokers
在线阅读 下载PDF
导出
摘要 目的探讨年轻吸烟者血清可溶性CD40配体(sCD40L)水平的变化。方法用ELISA法检测受试者血清sCD40L水平;用OlympusAU2700全自动生化分析仪检测受试者血清超敏C-反应蛋白(HSCRP)浓度。结果年轻吸烟者与对照组血清sCD40L和HSCRP水平分别为1.21±0.29ng/mL与0.37±0.21ng/mL和2.47±0.68mg/L与0.82±0.72mg/L,二者分别比较,差异有显著意义(P<0.05)。结论年轻吸烟者血清sCD40L升高,表明吸烟是心血管事件发生重要的风险因子。 Objective To investigate soluble CD40 ligand(sCD40L) modification in young smokers. Methods sCD40L was determined with ELISA and hypersensitive C - reactive protein (hsCRP) by Olympus AU2700 automated analyzer. Results sCD40L levels in young smokersand control group were 1.21±0.29ng/mL and 0. 37±0.21ng/mL, respectively, hsCBP concentrations in young smokers and control group were,respectively, 2.47±0.68mg/L and 0.82±0.72mg/L. Significant difference was observed ( P〈0.05). Conclusion sCD4OLand hsCRPconcentrations in young smokers were elevated. It is very useful to evaluate smoking as a cardiovascular risk factor.
出处 《中国热带医学》 CAS 2005年第6期1238-1238,1266,共2页 China Tropical Medicine
基金 广州市科技计划资助项目(2004Z3-E0441)
关键词 年轻吸烟者 可溶性CD40配体 血清 Young smokers Soluble CD40 ligand Serum
  • 相关文献

参考文献7

  • 1Lusis AJ. Atherosclerosis[J]. Nature.2000,407:233 - 241.
  • 2Heeschen C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acute coronary syndromes[J]. N Eng J Wed,2003,348:1104~ 1111.
  • 3Mach F, Schonbeck U, SukhovaGK, et al. FunctionalCD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages; implications for CD40- CD40 ligand signaling in atherosclerosis[J]. Pro Natl Acad Sci USA, 1997,94:1931 ~ 1936.
  • 4Heeschen C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acute coronary syndromes[J]. N Engl J Med,2003,348:1104 ~ 1111.
  • 5Mach F, Schonbeck U, Sukhova GK, et al. Reduction of atherosclerosis in mice by inhibition of CD40 signaling[ J]. Nature, 1998,394:200 ~ 203.
  • 6Varo N, Vicent D, Libby P, et al. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones[ J]. Circulation, 2003,107:2664 ~ 2669.
  • 7Garlichs CD, John S, Schmeiber A, et al. Upreguation of CD40 and CD40ligand ( CD 154) in patients with moderate hypercholesterolemia[ J ]. Circulation, 2001,104:2395 ~ 2400.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部